Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cells. (Q44732861)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cells. |
scientific article |
Statements
Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cells (English)
Sabine Zumstein-Mecker
Christine Stephan
Iwan Beuvink
Frederic Zilbermann
Roland Haller
Sonja Tobler
Christoph Heusser
Terence O'Reilly
Barbara Stolz
Andreas Marti
Heidi A Lane
1 January 2004